Status:
COMPLETED
Cervical Plexus Block Combined With Translaryngeal Block for Tracheostomy
Lead Sponsor:
Namik Kemal University
Conditions:
Regional Anesthesia Morbidity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Current healthcare delivery models emphasize enhanced postoperative recovery (ERAS) with minimal morbidity and shorter hospital stays. Most tracheostomy cases are tumour patients. The more the patient...
Detailed Description
after being informed and about the study and potential risks, all patients giving written informed consent will undergo 24 hours screening period to determine the eligilibity for study entry. After a ...
Eligibility Criteria
Inclusion
- Being in the age range of 18-65, with American Society of Anesthesiology (ASA) classification I-III and scheduled for elective or emergency tracheostomy.
- A sufficient level of education to understand the study procedures and agree to participate in the study
Exclusion
- inability to cooperate
- dementia,
- allergy to local anesthetics and opioids
- regular daily opioid requirements
- abuse of alcohol or medication
- local infection at the site of injection or systemic infection,
- pregnancy.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2020
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04697836
Start Date
March 1 2020
End Date
November 25 2020
Last Update
January 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Namık Kemal University
Tekirdağ, Süleymanpaşa, Turkey (Türkiye), 59100